Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.
作者信息
Rosendorff Clive, Lackland Daniel T, Allison Matthew, Aronow Wilbert S, Black Henry R, Blumenthal Roger S, Cannon Christopher P, de Lemos James A, Elliott William J, Findeiss Laura, Gersh Bernard J, Gore Joel M, Levy Daniel, Long Janet B, O'Connor Christopher M, O'Gara Patrick T, Ogedegbe Gbenga, Oparil Suzanne, White William B
出版信息
Circulation. 2015 May 12;131(19):e435-70. doi: 10.1161/CIR.0000000000000207. Epub 2015 Mar 31.
Abstract
摘要
相似文献
1
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.冠状动脉疾病患者的高血压治疗：美国心脏协会、美国心脏病学会和美国高血压学会的科学声明
Circulation. 2015 May 12;131(19):e435-70. doi: 10.1161/CIR.0000000000000207. Epub 2015 Mar 31.
2
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.冠状动脉疾病患者的高血压治疗：美国心脏协会、美国心脏病学会和美国高血压学会的科学声明
Hypertension. 2015 Jun;65(6):1372-407. doi: 10.1161/HYP.0000000000000018. Epub 2015 Mar 31.
3
Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.冠状动脉疾病患者的高血压治疗：美国心脏协会、美国心脏病学会和美国高血压学会的科学声明
J Am Soc Hypertens. 2015 Jun;9(6):453-98. doi: 10.1016/j.jash.2015.03.002. Epub 2015 Mar 31.
4
[Resistant hypertension: from prevention to renal denervation].[顽固性高血压：从预防到肾去神经支配]
Med Clin (Barc). 2013 Jul 7;141(1):27-8. doi: 10.1016/j.medcli.2012.11.023. Epub 2013 Jan 18.
5
Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations : A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension.高血压与冠状动脉疾病：流行病学、生理学、治疗效果及建议：奥地利心脏病学会和奥地利高血压学会联合科学声明
Wien Klin Wochenschr. 2016 Jul;128(13-14):467-79. doi: 10.1007/s00508-016-0998-5. Epub 2016 Jun 9.
6
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师助理学会/美国心脏病学学会/美国预防医学学院/美国老年医学会/美国药剂师协会/美国血液学会/美国预防医学学会/美国医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2018 Oct 23;138(17):e484-e594. doi: 10.1161/CIR.0000000000000596.
7
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师助理学会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药剂师协会/美国血液学会/美国预防心脏病学会/美国国家医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2018 Oct 23;138(17):e426-e483. doi: 10.1161/CIR.0000000000000597.
8
Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.欧美指南对高血压患病率、治疗和心血管代谢目标的影响。
J Hypertens. 2019 Jul;37(7):1393-1400. doi: 10.1097/HJH.0000000000002065.
9
Implications of new hypertension guidelines in the United States.美国新高血压指南的意义。
Hypertension. 2012 Sep;60(3):639-44. doi: 10.1161/HYPERTENSIONAHA.112.193714. Epub 2012 Aug 6.
10
Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017 年 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA 高血压防治、检测、评估和管理指南：美国心脏病学会/美国心脏协会临床实践指南工作组的报告
Circulation. 2018 Oct 23;138(17):e595-e616. doi: 10.1161/CIR.0000000000000601.
引用本文的文献
1
Long-term outcomes of patients with pre-existing coronary artery disease after SARS-CoV-2 infection.感染新型冠状病毒2（SARS-CoV-2）后原有冠状动脉疾病患者的长期预后
EBioMedicine. 2025 Jun;116:105778. doi: 10.1016/j.ebiom.2025.105778. Epub 2025 May 28.
2
Prevalence of Vitamin K2 Deficiency and Its Association with Coronary Artery Disease: A Case-Control Study.维生素K2缺乏症的患病率及其与冠状动脉疾病的关联：一项病例对照研究。
Diseases. 2025 Jan 11;13(1):12. doi: 10.3390/diseases13010012.
3
Cost-utility analysis of combination medical therapies in chronic coronary syndrome: a comparative study using real-world and patient-level data from Iran.慢性冠状动脉综合征联合药物治疗的成本效用分析：一项使用伊朗真实世界和患者层面数据的比较研究。
BMJ Open. 2025 Jan 14;15(1):e081953. doi: 10.1136/bmjopen-2023-081953.
4
2023 Guideline for the management of hypertension in the elderly population in China.《中国老年高血压管理指南（2023年版）》
J Geriatr Cardiol. 2024 Jun 28;21(6):589-630. doi: 10.26599/1671-5411.2024.06.001.
5
The Construction and Meaning of Race Within Hypertension Guidelines: A Systematic Scoping Review.高血压指南中种族的构建与意义：系统范围综述。
J Gen Intern Med. 2024 Oct;39(13):2531-2542. doi: 10.1007/s11606-024-08874-9. Epub 2024 Jul 1.
6
Dependable approaches to hypertension management: A review.可靠的高血压管理方法：综述。
Medicine (Baltimore). 2024 Jun 14;103(24):e38560. doi: 10.1097/MD.0000000000038560.
7
[MINICHAL and items predictors of worst quality of life in men with arterial hypertension].[小型量表及项目对男性高血压患者最差生活质量的预测因素]
Rev Esp Salud Publica. 2024 Mar 22;98:e202403026.
8
Proprotein convertase subtilisin/kexin type 9 (PCSK9) as a marker of coronary lesion severity in stable coronary artery disease (CAD) patients.前蛋白转化酶枯草杆菌蛋白酶/kexin 9型（PCSK9）作为稳定型冠状动脉疾病（CAD）患者冠状动脉病变严重程度的标志物。
Narra J. 2023 Dec;3(3):e409. doi: 10.52225/narra.v3i3.409. Epub 2023 Nov 12.
9
A phenomenological model of pulsatile blood pressure-affected degradation of polylactic acid (PLA) vascular stent.脉动血流血压影响聚乳酸（PLA）血管支架降解的现象学模型。
Med Biol Eng Comput. 2024 May;62(5):1347-1359. doi: 10.1007/s11517-023-02998-6. Epub 2024 Jan 6.
10
HDR-EfficientNet: A Classification of Hypertensive and Diabetic Retinopathy Using Optimize EfficientNet Architecture.HDR-EfficientNet：一种使用优化的EfficientNet架构对高血压性和糖尿病性视网膜病变进行的分类
Diagnostics (Basel). 2023 Oct 17;13(20):3236. doi: 10.3390/diagnostics13203236.
本文引用的文献
1
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2014年美国心脏病学会/美国心脏协会/美国胸外科医师协会/预防心血管护理协会/心血管造影和介入学会/胸外科医师学会对稳定型缺血性心脏病患者诊断和管理指南的重点更新：美国心脏病学会/美国心脏协会实践指南工作组、美国胸外科医师协会、预防心血管护理协会、心血管造影和介入学会以及胸外科医师学会的报告
Circulation. 2014 Nov 4;130(19):1749-67. doi: 10.1161/CIR.0000000000000095. Epub 2014 Jul 28.
2
A controlled trial of renal denervation for resistant hypertension.经导管射频消融去肾交感神经术治疗高血压的对照试验
N Engl J Med. 2014 Apr 10;370(15):1393-401. doi: 10.1056/NEJMoa1402670. Epub 2014 Mar 29.
3
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.影响卒中死亡率下降的因素：美国心脏协会/美国卒中协会的声明。
Stroke. 2014 Jan;45(1):315-53. doi: 10.1161/01.str.0000437068.30550.cf. Epub 2013 Dec 5.
4
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会心血管风险评估指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-2959. doi: 10.1016/j.jacc.2013.11.005. Epub 2013 Nov 12.
5
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.2013年美国心脏协会/美国心脏病学会/肥胖学会成人超重和肥胖管理指南：美国心脏病学会/美国心脏协会实践指南工作组及肥胖学会的报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38. doi: 10.1161/01.cir.0000437739.71477.ee. Epub 2013 Nov 12.
6
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏协会/美国心脏病学会降低心血管风险生活方式管理指南：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S76-99. doi: 10.1161/01.cir.0000437740.48606.d1. Epub 2013 Nov 12.
7
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013年欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理指南：欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理特别工作组
J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.
8
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南：执行摘要：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2013 Oct 15;128(16):1810-52. doi: 10.1161/CIR.0b013e31829e8807. Epub 2013 Jun 5.
9
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2012年美国心脏病学会基金会/美国心脏协会不稳定型心绞痛/非ST段抬高型心肌梗死患者管理指南重点更新纳入2007年美国心脏病学会基金会/美国心脏协会实践指南：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2013 Jun 11;127(23):e663-828. doi: 10.1161/CIR.0b013e31828478ac. Epub 2013 Apr 29.
10
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.外周动脉疾病患者的管理（2005年和2011年美国心脏病学会基金会/美国心脏协会指南推荐汇编）：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2013 Apr 2;127(13):1425-43. doi: 10.1161/CIR.0b013e31828b82aa. Epub 2013 Mar 1.
Zotero 插件